162 related articles for article (PubMed ID: 17175953)
1. [The role of the IPSS (International Prostate Symptoms Score) to evaluate the frequency of disability induced by each of the 7 symptoms. (CTMH-AFU study)].
de la Taille A; Desgrandchamps F; Haillot O; Saussine C; Lukacs B; Marc F;
Prog Urol; 2006 Nov; 16(5):568-71. PubMed ID: 17175953
[TBL] [Abstract][Full Text] [Related]
2. [Quality of life assessment of the male with benign prostate hypertrophy].
Nekić VC; Tiljak H; Petricek G; Soldo D; Nekić G; Buljan N
Acta Med Croatica; 2007 Feb; 61(1):49-55. PubMed ID: 17593641
[TBL] [Abstract][Full Text] [Related]
3. Relationship between lower urinary tract symptoms frequency assessed by the IPSS and bothersomeness (SPI) among men older than 50 years old.
Perrin P; Marionneau N; Cucherat M; Taieb C
Eur Urol; 2005 Oct; 48(4):601-7. PubMed ID: 16055260
[TBL] [Abstract][Full Text] [Related]
4. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting.
O'Leary MP; Wei JT; Roehrborn CG; Miner M;
BJU Int; 2008 Jun; 101(12):1531-5. PubMed ID: 18445080
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a new treatment outcome score for men with LUTS.
Weiss JP; Blaivas JG; Tash Anger JA; Di Blasio CJ; Panagopoulos G; Gerboc J
Neurourol Urodyn; 2004; 23(2):88-93. PubMed ID: 14983416
[TBL] [Abstract][Full Text] [Related]
6. Impact of lower urinary tract symptoms on discomfort in men aged between 50 and 80 years.
Robert G; Descazeaud A; Azzouzi R; Saussine C; Haillot O; Dumonceau O; Ballereau C; Fourmarier M; Devonec M; Lukacs B; Delongchamps NB; Desgrandchamps F; de la Taille A
Urol Int; 2010; 84(4):424-9. PubMed ID: 20339294
[TBL] [Abstract][Full Text] [Related]
7. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
[TBL] [Abstract][Full Text] [Related]
8. Relationship between lower urinary tract symptoms and objective measures of benign prostatic hyperplasia: a Chinese survey.
Wang JY; Liu M; Zhang YG; Zeng P; Ding Q; Huang J; He DL; Song B; Kong CZ; Pang J
Chin Med J (Engl); 2008 Oct; 121(20):2042-5. PubMed ID: 19080272
[TBL] [Abstract][Full Text] [Related]
9. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z
Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961
[TBL] [Abstract][Full Text] [Related]
10. Visual analog scale questionnaire to assess quality of life specific to each symptom of the International Prostate Symptom Score.
Ushijima S; Ukimura O; Okihara K; Mizutani Y; Kawauchi A; Miki T
J Urol; 2006 Aug; 176(2):665-71. PubMed ID: 16813918
[TBL] [Abstract][Full Text] [Related]
11. Association between lower urinary tract symptoms and erectile dysfunction.
Aslan G; Cavus E; Karas H; Oner O; Duran F; Esen A
Arch Androl; 2006; 52(3):155-62. PubMed ID: 16574595
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of storage and voiding symptoms among men aged 40 years and older in a US population-based study: results from the Male Attitudes Regarding Sexual Health study.
Glasser DB; Carson C; Kang JH; Laumann EO
Int J Clin Pract; 2007 Aug; 61(8):1294-300. PubMed ID: 17627708
[TBL] [Abstract][Full Text] [Related]
13. Adverse effect of radical prostatectomy on nocturia and voiding frequency symptoms.
Namiki S; Saito S; Ishidoya S; Tochigi T; Ioritani N; Yoshimura K; Terai A; Arai Y
Urology; 2005 Jul; 66(1):147-51. PubMed ID: 15992905
[TBL] [Abstract][Full Text] [Related]
14. Correlation of prostate volume with international prostate symptom score and quality of life in men with benign prostatic hyperplasia.
Agrawal CS; Chalise PR; Bhandari BB
Nepal Med Coll J; 2008 Jun; 10(2):104-7. PubMed ID: 18828432
[TBL] [Abstract][Full Text] [Related]
15. Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial.
Barkin J; Roehrborn CG; Siami P; Haillot O; Morrill B; Black L; Montorsi F;
BJU Int; 2009 Apr; 103(7):919-26. PubMed ID: 19239460
[TBL] [Abstract][Full Text] [Related]
16. Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate.
Chalise PR; Agrawal CS
Nepal Med Coll J; 2007 Dec; 9(4):255-8. PubMed ID: 18298015
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being.
Eckhardt MD; van Venrooij GE; van Melick HH; Boon TA
J Urol; 2001 Aug; 166(2):563-8. PubMed ID: 11458069
[TBL] [Abstract][Full Text] [Related]
18. [Symptom scores: what do they describe exactly?].
Pupca G; Patard JJ; Ziadé J; Guiraud P; Lobel B; Guillé F
Prog Urol; 2000 Sep; 10(4):561-7. PubMed ID: 11064897
[TBL] [Abstract][Full Text] [Related]
19. Impact of surgical treatment on nocturia in men with benign prostatic obstruction.
Cai T; Gardener N; Abraham L; Boddi V; Abrams P; Bartoletti R
BJU Int; 2006 Oct; 98(4):799-805. PubMed ID: 16978275
[TBL] [Abstract][Full Text] [Related]
20. Relevance and variability of the severity of incontinence, and increased daytime and night-time voiding frequency, associated with quality of life in men with lower urinary tract symptoms.
Haltbakk J; Hanestad BR; Hunskaar S
BJU Int; 2005 Jul; 96(1):83-7. PubMed ID: 15963126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
